← All Sponsors
SPONSOR

Riverside University Health System Medical Center

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Clostridium Difficile InfectionVancomycin Resistant Enterococci Infection
NCT07221370 Phase 2, Phase 3
Recruiting

Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

Clostridium Difficile Infection
United States View Trial →